BRISTOL, Tenn., Aug. 1 /PRNewswire-FirstCall/ -- King Pharmaceuticals,
Inc. (NYSE: KG) reported today that the Company plans to announce financial
results for the second quarter ending June 30, 2005, prior to the market open
on Tuesday, August 9, 2005. The Company also plans to provide a live
conference call to discuss its financial results beginning at 1:00 p.m. E.D.T.
later that same day. Conference call information will be provided when
available via a subsequent press release.
King, headquartered in Bristol, Tennessee, is a vertically integrated
pharmaceutical company that develops, manufactures, markets, and sells branded
prescription pharmaceutical products. King, an S&P 500 Index company, seeks
to capitalize on opportunities in the pharmaceutical industry through the
development, including through in-licensing arrangements and acquisitions, of
novel branded prescription pharmaceutical products in attractive markets and
the strategic acquisition of branded products that can benefit from focused
promotion and marketing and product life-cycle management.
This release contains forward-looking statements that reflect management's
current views of future events and operations, including, but not limited to,
statements pertaining to the anticipated date for release of the Company's
financial results for the second quarter ending June 30, 2005 and subsequent
conference call. These forward-looking statements involve certain significant
risks and uncertainties, and actual results may differ materially from the
forward-looking statements. An important factor that may cause results to
differ is whether King is able to release the Company's financial results for
second quarter ending June 30, 2005 and conduct its conference call as
currently planned on August 9, 2005. King does not undertake to publicly
update or revise any of its forward-looking statements even if experience or
future changes show that the indicated results or events will not be realized.
SOURCE King Pharmaceuticals, Inc.
 back to top
Related links:
http://www.kingpharm.com
Company News On-Call:
http://www.prnewswire.com/comp/120319.html
CONTACT:
James E. Green, Executive Vice President,
Corporate Affairs, +1-423-989-8125, or David E. Robinson, Senior
Director, Corporate Affairs, +1-423-989-7045, both of King
Pharmaceuticals, Inc.
|
